IBR2 |
Katalog-Nr.GC32912 |
IBR2 ist ein potenter und spezifischer RAD51-Inhibitor und hemmt die RAD51-vermittelte DNA-Doppelstrangbruchreparatur. IBR2 unterbricht die RAD51-Multimerisierung, beschleunigt den Proteasom-vermittelten RAD51-Proteinabbau, hemmt das Wachstum von Krebszellen und induziert Apoptose.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 313526-24-8
Sample solution is provided at 25 µL, 10mM.
IBR2 is a specific RAD51 inhibitor.
IBR2 shows interesting RAD51 inhibition activities. RAD51 is rapidly degraded in IBR2-treated cancer cells, and the homologous recombination repair is impaired, subsequently leading to cell death. The IC50 values of the original IBR2 are in the range of 12-20 µM for most tested cancer cell lines. IBR2 can inhibit the growth of triple-negative human breast cancer cell line MBA-MD-468 with an IC50 of 14.8 µM[1].
[1]. Zhu J, et al. Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. Eur J Med Chem. 2015;96:196-208.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *